I found this article titled: Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis.
To be certain, haemodialysis is serious business. Not fun at all. These were some sick people.
But look at these numbers:
Eleven patients on haemodialysis were treated with erythropoietin (EPO), 50-200 U kg-1 once to three times a week, for up to 1 year. After outset of EPO all patients became transfusion-independent.
Peak oxygen consumption (Vo2 peak), oxygen pulse, oxygen uptake at anaerobic threshold (AT) and total work output (W max) increased 19%, 36%, 26% and 24%, respectively. Lean body mass (LBM) increased by 8%. Taken together, all clinical EPO effects measured appeared clinically favourable.
The average net positive increase was an insane 26.25%.
I don’t know how much of that studies findings one can safely extrapolate to fit athletes. But even if it was half the benefit, say a 13% increase, you’re making a thoroughbred out of a donkey.
Or, you’re making something all together different out of mere human.
Every wonder where those superhuman efforts came from?
Now you know where. You know how. We all know.by